We are live on ! Find out more
JP Morgan Chase

JP Morgan Chase Portfolio holdings

AUM $1.56T
1-Year Est. Return 27.86%
 

JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.

This Fund
S&P 500
This Quarter Est. Return
+9.1%
1 Year Est. Return
+27.86%
3 Year Est. Return
+90.49%
5 Year Est. Return
+115.47%
10 Year Est. Return
+472.96%
AUM
$536B
AUM Growth
+$34.1B
Cap. Flow
-$10.8B
Cap. Flow %
-2.02%
Top 10 Hldgs %
16.91%
Holding
6,136
New
374
Increased
2,295
Reduced
2,258
Closed
490

Sector Composition

Rank Sector Weight
1 Technology 12.95%
2 Financials 11.95%
3 Healthcare 9.46%
4 Consumer Discretionary 8.62%
5 Industrials 6.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NRK icon
4976
Nuveen New York AMT-Free Quality Municipal Income Fund
NRK
$919M
$44K ﹤0.01%
+3,233
New +$43.3K
NZF icon
4977
Nuveen Municipal Credit Income Fund
NZF
$2.42B
$44K ﹤0.01%
+2,678
New +$43.2K
CBAY
4978
DELISTED
Cymabay Therapeutics
CBAY
$44K ﹤0.01%
22,583
-460,816
-95% -$1.73M
NID
4979
DELISTED
NUVEEN INTERMEDIATE DURATION MUNICIPAL TERM FUND
NID
$44K ﹤0.01%
+3,184
New +$43.9K
ACIU icon
4980
AC Immune
ACIU
$259M
$43K ﹤0.01%
+5,059
New +$33.7K
ALDX icon
4981
Aldeyra Therapeutics
ALDX
$91.1M
$43K ﹤0.01%
7,394
-26,929
-78% -$156K
FNDE icon
4982
Schwab Fundamental Emerging Markets Large Company Index ETF
FNDE
$9.96B
$43K ﹤0.01%
1,437
IMCB icon
4983
iShares Morningstar Mid-Cap ETF
IMCB
$1.71B
$43K ﹤0.01%
+812
New +$41.2K
NL icon
4984
NLI Holdings
NL
$313M
$43K ﹤0.01%
10,952
+8,210
+299% +$33.7K
VGLT icon
4985
Vanguard Long-Term Treasury ETF
VGLT
$10.3B
$43K ﹤0.01%
513
+3
+0.6% +$256
BXC icon
4986
BlueLinx
BXC
$706M
$42K ﹤0.01%
2,950
-1,038
-26% -$21.3K
XFOR icon
4987
X4 Pharmaceuticals
XFOR
$424M
$42K ﹤0.01%
130
NYMX
4988
DELISTED
Nymox Pharmaceutical Corp
NYMX
$42K ﹤0.01%
18,930
-907
-5% -$1.79K
CRK icon
4989
Comstock Resources
CRK
$4.23B
$41K ﹤0.01%
4,946
+8
+0.2% +$56
CVNA icon
4990
Carvana
CVNA
$79.2B
$41K ﹤0.01%
2,220
-2,134,575
-100% -$35.7M
OBDC icon
4991
Blue Owl Capital
OBDC
$5.76B
$41K ﹤0.01%
+2,300
New +$40.2K
SDIV icon
4992
Global X SuperDividend ETF
SDIV
$1.21B
$41K ﹤0.01%
+766
New +$39.5K
CVIA
4993
DELISTED
Covia Holdings Corporation Common Stock
CVIA
$41K ﹤0.01%
19,943
-96,516
-83% -$156K
BPT
4994
DELISTED
BP Prudhoe Bay Royalty Trust
BPT
$40K ﹤0.01%
5,791
-11
-0.2% -$82
BUI icon
4995
BlackRock Utilities, Infrastructure & Power Opportunities Trust
BUI
$713M
$40K ﹤0.01%
1,800
EVI icon
4996
EVI Industries
EVI
$187M
$40K ﹤0.01%
1,490
ISCG icon
4997
iShares Morningstar Small-Cap Growth ETF
ISCG
$1.01B
$40K ﹤0.01%
1,140
+432
+61% +$14.7K
SIVR icon
4998
abrdn Physical Silver Shares ETF
SIVR
$4.5B
$40K ﹤0.01%
2,337
+1,700
+267% +$28.6K
VALU icon
4999
Value Line
VALU
$375M
$40K ﹤0.01%
1,384
+1,037
+299% +$26.5K
ZYXI
5000
DELISTED
Zynex
ZYXI
$40K ﹤0.01%
5,640
+24
+0.4% +$211

Similar funds

JP Morgan Chase's Q4 2019 Portfolio in Review

As of Q4 2019, JP Morgan Chase held 6,136 positions worth $536B, up 6.8% from $502B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

JP Morgan Chase's Q4 2019 filing shows 374 new, 2,295 increased, 2,258 reduced and 490 closed positions. Its largest new stake was XP: 4,912,590 shares worth $189M. The largest sale was Pfizer, an estimated $1.43B.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.

  • JP Morgan Chase's largest Q4 2019 buy was XP: 4,912,590 shares worth $189M.
  • JP Morgan Chase added most to iShares 20+ Year Treasury Bond ETF in Q4 2019, an estimated $1.04B increase.
  • JP Morgan Chase's biggest Q4 2019 reduction was Pfizer, cutting an estimated $1.43B.
  • JP Morgan Chase fully exited SunTrust Banks, Inc. in Q4 2019, selling an estimated $987M.
  • JP Morgan Chase's ten largest holdings make up 17% of its $536B portfolio in Q4 2019.
  • JP Morgan Chase opened 374 new positions and closed 490 in Q4 2019.
  • JP Morgan Chase's portfolio value rose 6.8% quarter-over-quarter to $536B.

Based on JP Morgan Chase's 13F filing for Q4 2019, filed 11 Feb 2020.